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Abstract
Malaria, the severe vector-borne disease has embedded serious consequences on 
mankind since ages, causing deterioration of health, leading to deaths. The caus-
ative parasite has a wide distribution aligned from tropical to subtropical regions. 
Out of all the five species Plasmodium vivax and Plasmodium falciparum have 
registered about more than 600 million cases worldwide. Throughout the decades, 
identification of various antimalarial drugs, targets, preventive measures and 
advancement of vaccines were achieved. The key to executing malaria elimination 
is the appropriate laboratory diagnosis. Development includes positive scientific 
judgments for a vaccine, advanced progress of 3 non-pyrethroid insecticides, 
novel genetic technologies, possibilities to alter malaria parasite mediation by the 
mosquito, identification of drug resistance markers, initiation of Plasmodium vivax 
liver stage assessment, perspective to mathematical modeling and screening for 
active ingredients for drugs and insecticides. Although the last century witnessed 
many successful programs with scientific progress, however, this was matched with 
notable obstacles. The mutation in the genes has changed the overall gameplay of 
eradication. This chapter aims to examine the numerous experimental and theoreti-
cal works that have been established in the last two decades along with the ongoing 
methodologies consisting of detailed explanations necessary for the establishment 
of new targets and drugs.
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1. Introduction
Malaria has been a curse to mankind since early ages. It is initiated by a protozoan 
parasite, infecting the human circulation system. The disease is distributed through-
out the tropical and subtropical regions, with transmission caused mainly through 
the Anopheles mosquitoes [1, 2]. In 2018, there were cases of about 228 million around 
the world which resulted in deaths of about 405,000 people. Initially four different 
parasite species were reported for transmission. Recently, Plasmodium knowlesi, a 
simian parasite, has been identified as a sporadic source of certain human infections, 
in the areas of Southeast Asia [3, 4], thus, raising the number to five species. The 
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Plasmodium falciparum species are spread worldwide and has an ability to inhibit the 
host physiology during the infection, making it more fatal as compared to  
other species [5].
Experimental study in 1991 showed that Plasmodium falciparum gradually 
evolved from two avian parasites which later got transferred to human [6]. 
However, in 2011, it was found that the parasite P. falciparum actually arose 
from P. praefalciparum rather than directly originating from the avian parasite 
and eventually got segregated into human parasites. The parasite basically 
infects humans, gorillas and chimpanzees, and P. falciparum of the Laverania 
family is the only species that flourishingly got transferred from apes to 
humans [7].
Development of vaccines is another way to overcome the burden of malaria 
in lieu of drugs. Unfortunately, the complicated biology, diverse genome and the 
life cycle of the malarial parasite has been obstructing the vaccine development 
process thus; no effective vaccination (licensed) has been approved against malaria 
[8]. The available vaccines can be categorized into: attenuated forms of microbes, 
inactivated microbes or protein-based subunit [9]. Recent parasitologist had made 
an attempt to manufacture a vaccine that can produce entire parasites in adequate 
quantities to stimulate immunity [10].
1.1 Treatment regimes
A remarkable progress has been achieved in the mission of eradication of 
malaria from mosquito nets to artemisinin-based combination therapies (ACTs). 
In 1820, Quinine, the world’s first anti-malarial drug was introduced. It was 
isolated from the cinchona’s bark and was administered as tonic water. Later on, 
various natural as well as synthetic compounds were introduced [11]. However, 
the development of drug resistance for the existing drug led to a failure of the 
treatment. Drugs with improved efficacy and potency were introduced to deal with 
the resistance. Recent study on drug resistance showed that de novo resistances are 
appearing more rapidly [12, 13]. The first case of drug resistance ever reported was 
in 1980, it was against Quinine [14].
In order to overcome drug resistance, the antimalarial drugs were adminis-
tered through a combination treatment called Artemisinin-based combination 
therapy (ACT). The artemisinin and its derivatives compounds are still used as 
antimalarial drugs during the parasite stages [15, 16]. The world health organiza-
tion (WHO) still suggests the use of ACT against falciparum [17]. Currently, 
Plasmodium falciparum has almost developed resistance for every drug available 
[18]. The list of drug molecules undergoing clinical trials (last two decades) is 
given in Table 1 [19]. So, there is a desperate need for new antimalarial drugs in 
the market.
To tackle the high morbidity and mortality caused by malarial parasites chiefly 
in young children, a global malaria control strategy, prompt and explicit diagnosis 
with treatment of malaria is indispensable to accomplish a convenient cure, along 
with developing numerous drugs against it. However, various surveys described and 
reported resistance for pretty much all available antimalarial drugs that broaden the 
vital requirement for the development of new antimalarial drugs against substanti-
ated existing targets, and to initiate search for novel targets in order to eradicate the 
speedily mutating parasites.
In this chapter, we have discussed the recent computational as well as experi-
mental procedures that have taken place in order to facilitate the diagnosis along 
with the development of new antimalarial drugs in the last two decades.
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2. Experimental approaches concerning detection of malaria
For the detection and diagnosis of malaria-parasite infections and to tackle it 
effectively, multiple experimental procedures have been established to meet the specific 
demands during the entire diagnosis process. In this chapter we have mentioned the 
recently reviewed and developed strategies of standard means which include micro-
scopic procedures, RDT or the rapid diagnostic tests, immunochromatographic tests, 
and molecular level identification, signified by systems based on PCR, additionally its 
limitations with recent trends on several new methodologies. These analyses provide 
practical comparisons, clarification and the feasibility between distinct diagnostic tests.
2.1 Routine laboratory diagnosis
Instant malaria diagnosis with productive outcomes reduces the probability of 
infection and minimizes community spreading as well. Hence, malaria is initially 
identified in the laboratory, employing different techniques. These procedures pos-
sess several advantages along with some shortcomings due to which recent modifi-
cations and new laboratory methodologies are being applied for future operations.
2.1.1 Blood smear as stained films
For malaria recognition, the laboratory procedure undertaken is the preparation 
with microscopic analysis of Giemsa, Field’s or Wright’s stained films of blood. Thick 
Drug Name Year Mechanism of Action
AQ 13 2007 Not resolved so far
OZ277+ Piperaquine 2007 check the Pf-encoded sarcoplasmic endoplasmic 
reticulum calcium ATPase




2012 Restricting choline transfer within the parasite
P218 2012 PfDHFR inhibitor
KAF156 Ganaplacide/
lumefantrine
2014 Not yet resolved
SJ733 2014 The P-type Na + –ATPase transporter
Sevuparin (DF02) 2014 Anti-adhesive polysaccharide derived Blocks 
merozoite invasion and sequestration
M5717 (DDD498) 2015 It inhibits PfeEF2, where an attaching pocket for 
M5717 was not explained.




Artefenomel (oz439) + Piperaquine 2016 Synthetic endoperoxide
DSM265 2017 Suppress dihydroorotate dehydrogenase enzyme
Methylene Blue 2017 Inhibits P. falciparum glutathione reductase to check 
haem polymerization
MMV390048 2017 Phosphatidylinositol 4-kinase (PfPI4K) inhibitor
Table 1. 
List of the ongoing clinical trial carried out for as drug against malaria in the last two decades (2000–2020).
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and thin smear of blood are taken either by needling a finger or an earlobe. Evolved 
trophozoites are measured by their densities which are prominent in blood mainly 
in the regions where abundant capillaries are found; hence, it is the ideal specimen. 
Blood acquired by puncture of veins, gets accumulated in the covering of EDTA or 
heparin anticoagulant channel, is sustainable whenever it is utilized for the closure in 
the modification of the leukocytes structure along with the parasites [20, 21].
2.1.1.1 Blood film (thin)
Methanol and Giemsa or Wright’s stain (diluted) is used to fix and stain 
respectively for the preparation of thin blood smear (film) and moderate water is 
employed at pH of 7.2. Since, in this technique, fixed RBC monolayer is obtained, 
parasite recognition by morphology is done at the stage of species and the particu-
larity is raised in comparison to the study by the thick film. Further infections, 
where reactions for remedy can be examined, are done by the capability to add 
parasites in the sequential blood films.
2.1.1.2 Blood film (thick)
The red blood cells are centralized by the thick blood smear on the compact 
side and are stained as an immense composition by staining with Field, Wright or 
Giemsa techniques. This blood film method has very intense sensitivity as the blood 
elements are more concentrated. This is due to the thick smear of blood and is used 
for the observation of less quantity of parasitemia. It is vastly superior than the 
thin film with returning the passing on of parasites throughout the infectious phase 
restoration or degeneration [22].
2.1.1.3 Application example of microscopic inspection of blood smears
A comparative analysis was undertaken by Cortés et al., in 2018 of the technique 
originated and put forward by the world health organization, and employed for 
the pre-elimination programs and detection with cure of malaria in Colombia. The 
acceptable procedure was the thick film (two) composition which is stained by the 
improved Romanowsky stain in the same slide with its technical characteristics, of 
storage, low cost, usage along with a cure for the diagnosis of malaria which was 
from the consequences after the investigation [23].
2.1.2 Fluorescence microscopy
Substitute methodologies are established to intensify the blood film based 
recognition of malarial parasites. Specific dyes that are fluorescent have empathy 
for the genetic material present in the nucleus of the parasite that must affix in 
its nuclei. The nucleus becomes excessively luminant when UV light is used at a 
proper distance to excite it. Fluorochromes often used are acridine orange as well 
as benzothiocarboxypurine, both when energized gives fluorescence of yellow or 
apple green at 490 nm. Rhodamine-123 is beneficial in order to evaluate the para-
site’s feasible condition, when in consideration to the absorption that depends on 
the entire working parasitic membrane [24].
2.1.2.1 Acridine orange (AO)
AO is a staining technique which is directed or combined to an assembly practice 
like the thick smear of blood employed in numerous procedures. By employing a 
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particular long focal length objective accompanying a fluorescence microscope, the 
capillary tube can be helpful for the verification of the parasites. Within the passage 
of the transmitted beam of light an excitation filter is organized and enrolled by 
the simpler Kawamoto technique as well as permitting the affected wavelength of 
AO which is 470 to 490 nm, to move through the film stained. Additionally, in the 
ocular another filter of 510 nm has been set for making comprehensible AO stained 
fluorescing parasites observation.
2.1.2.2 Benzothiocarboxypurine (BCP)
BCP is another methodology utilized that can be put into a dry film of blood or 
in a suspension of lysed blood, unfixed along with profoundly staining the nucleic 
acid of feasible P. falciparum parasites. Inversely, the nuclei of leukocytes and RBC 
inclusions are not stained properly. The necessity of speedy investigation to halt 
precipitation of the dye is controlled by this activity, which was characteristic in 
some fluorescence systems. This element is noticed as a delicate and quick detec-
tion medium, similar to the staining by Giemsa stain, in various reports described 
mainly as P. falciparum having 95% sensitivity along with its specificity. Further, in 
the thick-film composition, the non-P. falciparum parasites are effortlessly recog-
nizable compared to the QBC buffy coat. Workers having practice and performing 
these procedures where components with fluorochromes are involved can distin-
guish the parasites quickly and accurately.
Nowadays, fluorescent microscopes that are transportable and apply light 
emitting diode mechanization, glass slides that are pre-prepared as well as parasites 
labelling using fluorescent indicators, are accessible commercially [25].
2.1.3 Rapid diagnostic tests (non-microscopic)
Rapid diagnostic tests or RDTs are another very effective assay for the diagnosis 
of malaria which are contributing as a fascinating substitute for microscopy, detect-
ing malaria parasite antigens and enzymes and forms the foundation of diagnosis 
in various impoverished areas where laboratory approaches are rare. Employing 
an immunochromatographic method, the RDT uses monoclonal antibodies to 
determine the antigen of malaria in 5 to 15 μL blood which is aimed at antigens 
specific utilizing a test strip for its permeation. The outcomes of these assays may 
be acquired in between 5 to 20 minutes that are elucidated from lines which are col-
ored, present/absent on the strip. Aldolase (P. falciparum histidine rich protein II) 
and Plasmodium lactate dehydrogenase are identified by these tests. Considerably, 
for the differentiation of non-falciparum in between the falciparum infections, 
results from these procedures integrate any two among all the antigens for an 
attempt.The results from these test mechanisms are less accurate than outcomes 
obtained from microscopy achieved under routine field circumstances [26, 27].
2.1.4 Immunochromatographic assays
Immunochromatographic assays also known as Immunochromatography, over 
the surface of nitrocellulose membrane liquid, are relocated. In opposition to a tar-
get that is an antigen of malaria in conjugation with liposome constituting mobile 
phase with either gold particles or selenium dye, these methods got accepted with 
detainment of antigen from parasite obtained in peripheral blood and monoclo-
nal antibodies are used in the entire process. During the immobile phase, a strip 
of nitrocellulose is taken where monoclonal antibodies are put in, which is the 
second/third capture. During the mobile phase, the antigen–antibody complex is 
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migrated alongside the strip, which permits the antigen labeled to record through 
the monoclonal antibody in the immobile phase constructing a colored visible line. 
Various physical features of the component reagents are crucial for migration and 
it is clear that the system is controlled for migration when a labeled goat anti mouse 
antibody capture is incorporated [28, 29].
2.1.5 Immunochromatographic dipstick assays
RDT dipstick format is another assay and is commercially accessible with its kits 
for the investigation of malarial antigens. In many laboratory investigations, compari-
son of immunochromatographic as well as conclusion acquired from PCR and also 
microscopic procedures has been examined. Even though some constructors of HRP-2 
tests exist without the availability of published records, experiments for HRP-2 detec-
tion including ParaSight, ICT Pf or Pf/Pv together with PATH falciparum Malaria IC 
analysis was carried out on a large scale which are commercial dipstick trials.
For the P. falciparum identification in samples of blood, average sensitivity 
between 77% and 98% in attendance of 100 parasites/1micro liter with 0.002% 
parasitemia was resulted from experimental methodologies using ParaSight F 
immunochromatographic process of HRP-2. When compared with microscopic 
technique of thick blood smear, specificity between 83% and 98% for P. falciparum 
was obtained. The incapability of the viewer for the parasite exposure employing 
microscopic tests at densities reduced to 200 parasites/l or the failure of indistinct 
positive lines observation from the test strip is reflected by the insignificant level of 
sensitivity from multiple analysis [30, 31].
2.1.5.1 Application example of Rapid diagnostic tests
Speculative treatment with anti-malarial to all feverish patients gives rise to 
enormous over-treatment. Accordingly, it was directed to reduce drastically over-
treatment with antimalarials on its prescription to evaluate malaria rapid diagnostic 
tests execution consequences at urban Tanzania, which was studied by D’Acremont 
et al., in 2011. Clinician experts with appropriate encouragement assemble with 
guidance of negative result patients for not treating them. Thus, to prevent unjus-
tifiable use of antibiotics, execution of mRDT should be unified closely besides 
instructions for the control of various fever origins [27].
For the extraction of overall nucleic acid from operated mRDTs, Guirou et al. 
recently investigated and constructed and considerably estimated a technique. 
The observation along with the measurement of P. falciparum from patients with 
asymptomatic behavior by reverse transcription quantitative PCR which is allowed 
by the isolation of nucleic acids from low volumes of blood retained (dried) on the 
RDTs. Based on the procedure of separation they assembled Extraction of Nucleic 
Acids with RDTs procedure, an absolute advancement of extensive molecular 
malarial supervision. ENAR furnishes a strong mechanism to examine RNA and 
DNA from numerous RDTs in a high throughput and standardized way, disclosed 
during a review of malaria benchmarks employing RDTs collected. Finally, they got 
various novel and previously existed polymorphisms spreading in the Bioko Island 
of Equatorial Guinea, which were of single nucleotide and non-synonymous in the 
propeller zone of the kelch 13 gene [32].
2.1.6 Molecular diagnostic procedures
Molecular diagnostic techniques are the inspections where genetic material or 
the nucleic acids are being targeted and are verified as frequent, certain and acute 
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processes. Nucleic acid tests choose gene sequences like the P. falciparum STEVOR 
multigene family, 18 s ribosomal RNA gene sequences, telomere-associated repeti-
tive component and mitochondrial DNA. Recent progresses in various molecular 
biological mechanisms including PCR and loop-mediated isothermal amplification 
(LAMP) have allowed considerable description of the malaria parasite which is 
bringing new approaches for malaria diagnosis.
2.1.6.1 PCR based methods
Recently, a number of PCR assays came into existence during malaria detec-
tion at a molecular level and among various other methods, it is manifested 
considerably as very sensitive and distinct techniques, particularly for low 
parasitemia or mixed infection examples. Beneficial knowledge is offered by 
multiplex and nested PCR mechanisms when demanding structural issues occur 
throughout the strive to recognize the species level parasites. A minimum of 1 to 
5 parasites/μl blood approximated about 50 to 100 parasites/μl blood from RDT 
and microscopy can be recognized by PCR techniques. The species picked out is 
validated from the methods using reverse transcription PCR along with nested 
PCR. Parasites of malaria can be detected upto species level even in patients of 
minimum parasitemia level, and is the chief benefit of employing techniques 
that are PCR based. And these systems mostly investigate mutations and strain 
variation. Moreover, PCR can assist spot and examine parasite genes interrelated 
to mixed infections or drug resistance and also maximum numbers of specimens 
might be automated [33, 34].
2.1.6.2 LAMP technique
The Loop-mediated isothermal amplification (LAMP) technique is an additional 
nucleic acid method. This process has the possibilities of making adjustable strate-
gies field based on nucleic acid, since low PCR with instrumentation is only needed 
and is effortless. Unlike PCR, amplification takes place at a constant temperature in 
LAMP and is an isothermal procedure.
In comparison to PCR, LAMP utilizes primers of three sets thus, challenging 
PCR in terms of quantity of DNA. The amplification can be determined in real time 
by checking the rise in the magnesium pyrophosphate quantity viz. turbidimetry. 
PCR is expensive and less sensitive than LAMP, which is also an uncomplicated 
approach, yet it has the downside for the necessity of a low temperature repository 
of reagents [35, 36].
2.1.6.3 Application example of PCR based methods
A study by Calderaro et al., in 2018 analyzed the current mode of imported 
malaria with revised inquiry as well as described the case results with their treat-
ment, throughout January 2013 to June 2017, in Parma, Italy, with surveying the 
differentiation of the three indicative methods employed detection of malaria: 
microscopic techniques, Real-time PCR and immunochromatographic tests 
identifying, Plasmodium malariae, Plasmodium falciparum, Plasmodium vivax, 
Plasmodium knowlesi, Plasmodium ovale curtisi and Plasmodium ovale wallikeri. In 
their research, within the non-endemic areas, without multiple classic symptoms 
in different cases, the clinicians might get encouraged from the data described to 
doubt as malaria and to explain by parasitologists, the outcome of microscopic 
methods, other recommended procedures, and methodologies of molecular level to 
keep away from mis-detection [37].
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A research from the Reference Laboratory for final malaria interpretation 
resembled the identification from laboratories of peripheral Belgian by Loomans 
et al., in 2019. The records of The Reference Laboratory for each specimen submit-
ted in 2013–2017 were examined. As a result, very adequate malaria recognition 
mostly of P. falciparum was provided by the laboratories in a malaria non-endemic 
environment, with P. falciparum parasite density calculations and standard identi-
fication of non-falciparum infection [38].
2.2 Disadvantages and recent trends
The microscopic inspection in smears of blood, RDTs or rapid diagnostic tests 
with molecular or nucleic acid based methods consists of particular defects and 
restrictions in constructive utilization at environments where sufficient resources 
are not available. The enrichment and detachment without disrupting the para-
site, which could not be acquired from these systems, might be crucial in malaria 
parasite study. To intensify the observation of iRBCs, further new practices were 
implemented by some research teams. Utilization of non-woven fabric size based 
filtration is one of the simple and inexpensive methodologies. Out of numerous 
other procedures, magnetophoretic with dielectrophoretic concepts are possessing 
pleasing prospects in the verification of malarial parasite recently, because of indi-
vidual conversions with magnetic as well as electrical effects of hRBCs in contrast 
to iRBCs.
Furthermore, other procedures, in particular, deformability in addition to 
cell morphology, seemed acceptable for future use as biomarkers. An excessive 
magnetic field gradient can be generated by a Magnetic-field generating system 
throughout an immense region [39]. Next explanation is a mixture of more than 
two diagnostic assays, to raise the specificity to iRBCs, thus amplifying the capacity 
to detect and separate malaria and infected erythrocyte respectively.
3. Computational approaches against eradication of P. falciparum
Potential inhibitors against P. falciparum have been identified using different 
approaches like high-throughput screening (HTS) and drug discovery based on 
target approach. The HTS approach consists of identification of novel and effec-
tive inhibitors which facilitates the development of hits and validation of leads. 
The action mechanism of the leads, once validated, is identified. The advantage 
of this mechanism is that it helps to directly identify active compounds. Once the 
active compounds are successfully identified, the targets of only those compounds 
are validated. Another approach to drug discovery is target-based. This approach 
exploits the information of the target and thus, identifies new inhibitors using this 
information.
3.1 System biology approach
Establishing a target is a crucial part in drug discovery. In the past two decades 
few targets have been established as potential targets against antitubercular drugs. 
Target identification is mostly achieved by biochemical methods, genetic inter-
action or any other computational methods. In computational methods, target 
establishment involves gaining a detailed knowledge at atomic level along with 
study of structures of proteins, sequences of genes, pathways (metabolic) and 
protein–protein interactions (PPI) [40]. In a nutshell, finding a protein/receptor as 
a target, where a lead compound, a potent drug, may bind. Using the genetic data, 
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various techniques have been approved for searching a potent drug target. They can 
be summarized into four groups: Gene-to-Target method, Disease-to-Target method, 
Gene network and protein–protein interaction network.
3.1.1 Gene-to-target method
Initially, the common drug target classes were selected, later, computational 
techniques have been used to determine a new target and predict its function. 
Kinases protein, G-protein coupled receptors (GPCRs), the ions channel, and 
nuclear receptors are successfully established target classes.
After target class identification screening of possible new gene candidates 
is done from the sequence database. New gene candidates not only allow us in 
discovering new targets but also help us in understanding the disease at molecu-
lar level.
The human genome database contains a vast number of gene coding new 
proteins, thus, data mining the database can reveal new essential candidates of the 
target class. BLAST is the most commonly used technique for finding the similar 
sequence from the database. Sometimes more sophisticated approach viz., PRINTS 
are used. However, this limitation can be controlled using various in-silico tech-
niques which include features like physiochemical properties, amino acid composi-
tions etc.
The expressed sequence tags (ESTs) allow us resources for characterization of 
gene, identification of new gene and expression of gene with specific tissue. The 
EST database (dbEST) not only helps in identifying new genes of the class target 
but also expression of gene Wittenberger et al. illustrated an EST database method 
to search for a new member of the superfamily, GPCR. They have found about 14 
new members as new putative for GPCRs [41].
Gene function identification is one of the most essential parts for drug 
discovery. Function prediction is proved to be a difficult task, even species like 
Escherichia coli contain about ~30% genes whose-of gene’s functions are still 
unknown. Similarly, in Plasmodium falciparum about ~60% of the genes are 
lacking their function [42]. The approaches for gene function prediction are still 
way back than lagging behind as compared to the progress that has been made in 
genome sequencing [43].
3.1.2 Disease-to-target method
Identifying a target requires the study of the origin of the disease and their rela-
tion with the system. This method initially focuses on one specific disease and later 
on various approaches like expression of gene and analysis of linkage are acquired 
for identifying disease related genes along with potent targets for drugs.
Hundreds of gene expressions can be generated and utilized to identify disease 
related genes and potent target thorough microarray. Microarray techniques, apart 
from identifying gene targets and pathways, also allow us to understand the biologi-
cal process of the disease. Identification of the target can be done by understanding 
how a potent drug or compound influences a particular metabolic pathway or 
regulates a network in cellular metabolism.
Predicted disease models that are used during experimentation can be used 
for validating a target. Thus, a disease model at the molecular level predicts the 
compounds that are best against the disease and also to perform the binding of the 
ligand through in-silico. Pettipher et al. have used this approach to find out inflam-
matory diseases associated with GPCRs. This leads to identification of new targets 
associated with genetics [44].
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3.1.3 Gene network method
This method deals with the modeling of signaling, endogenous metabolic and 
regulatory networks along with potent drugs interacting with targets. This helps 
in recognizing if a target is inhibited and it resulted in inhibition of other activities 
which are in relation with that pathway. The interactions of genes are essential for 
studying the structure, functions and the organism’s response. There is a possibility 
of deducing the gene network predictive model by the over expression of the gene 
present in the network and calculating the overall expression result of the entire 
gene during a stable state in the gene network. Simulation and analysis through 
mathematics can make a successful prediction. Various computational approaches 
have been approved as equation models, Bayesian networks and Boolean networks 
for deducing regulatory gene networks.
3.1.4 Protein–protein interactions (PPIs) network
In the drug discovery process proteins act as the main target. The expression of 
protein on both the normal and the diseased one plays a crucial role in drug targets 
and drugs development. PPI network is one of the methods for identifying essential 
drug targets. The interaction map of protein shows the important pathways which 
can be studied for target identification. They are further validated in the biological 
model. Although there are hundreds of pathways associated with a disease metabo-
lism, the main role is picking out an essential node in the complex gene or protein 
network which can be utilized as a potent target [45]. The graphical representation 
of the pathway can estimate the overall topology and target node but the behavior 
of cell response is quite limited. To overcome this kinetic model approach was 
adapted.
In the static network method the constructed network is analyzed using vari-
ous topological analyses which can be related to various functions and regulation 
mechanisms. Further a constructed static network can be compared with a well-
known network thus, revealing various unknown biological functions of the system 
[46]. Some examples are Cytoscape, String and Gephi.
Kinetic model is also known as the mathematical approach used to determine the 
dynamics of the biological system. The model can be validated under various envi-
ronments. The kinetic model uses some of the reaction parameters viz. Michaelis 
constant (Km), turnover number (Kcat) and enzyme concentration (E0). In absence 
of experimentally estimated parameters, parametric estimation methods and Monte 
Carlo are used [47].
In this context, Bora et al. have selected about 39 proteins out of which 15 
proteins were screened out for further studies. This protein’s interaction was 
retrieved from the STRING database. The filtered proteins along with their 
interacting protein are subjected to cytoscape to create a network. Further for 
mutant modeling and structure analysis the Adenylosuccinate lyase (ADSL) 
is selected. The docking resulted in ADSL complex, docked with AMP. MD 
simulation is performed for stability analysis [48]. Bora et al. have performed 
a computational study on Leishmania donovani, integrating PPI with metabolic 
pathways. Purine salvage pathway was considered for the study and the overall 
biochemical reactions were taken from the KEGG database, then the kinetic 
model was subjected to simulation in “COPASI”. Finally, the PPI of L. donovani is 
derived from “STRING version 10.5” which was analyzed in Cytoscape using the 
cytohubba plugin [49].
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3.1.4.1  Application examples of target identification against P. falciparum using 
systems biology approach
P. falciparum PPIs were identified using high-throughput kind of yeast-two 
hybrid assay. LaCount et al. identified about 2,846 new interactions of which most 
of them were uncharacterized proteins. Further, the in-silico analysis of PPIs con-
nectivity of the network, gene expression which are coding for interacting segments 
and Gene Ontology were done to identify protein interacting with mRNA, tran-
scription, modification of chromatin and those taking part in the invasion of the 
host cell [50]. Proteins having topology associated with significant graphs and high 
degree were considered as drug targets.
Saha et al. have made a case study of pathogens (P. falciparum) with host 
(Human). PPIs of both interacting with each other are derived from the STRING 
database. The node weight and edge weight has been computed simultaneously. 
Protein’s centrality and connectedness values play a crucial role in organization of 
function. The node and network centrality identifies the most important protein 
in the network. Around 457 new interactions were identified of which 198 bait 
proteins and 217 prey proteins were mapped to the STRING database. Further, 
PANTHER was used for the analysis of functional similarity [51].
3.2 Bioinformatics approach
Bioinformatics approach facilitates identification of targets for drugs, drug 
molecules and screening of compounds. In addition to this it also scrutinized the 
side effects along with prediction of resistance of drugs. It covers almost every 
aspect of mechanism drug discovery through data of high throughput [52]. Apart 
from this homology modeling and protein simulation covers the field for more 
vivid virtual screening and docking studies.
3.2.1 Protein structure prediction
Tertiary structure of protein is the most essential requirement for studying 
the folding, unfolding along with the function of a protein. But determining the 
structure is not always easy. X-ray crystallography, nuclear magnetic resonance 
(NMR spectroscopy) and Cryo-electron microscopy (Cryo-EM) are the major 
techniques used for prediction of the protein 3D structure. But each of them has 
its own limitation keeping aside the cost part. In the past few decades computa-
tional techniques have developed quite a lot. Predicting the 3D structure not only 
allows studying the folding and unfolding of the protein but also may facilitate 
new function in a protein. The tertiary structure of proteins is mainly achieved in 
three ways:
3.2.1.1 Based on empirical energy calculations
Energy minimization, also known as ab-initio, is a way of predicting protein 
structure. The structure is established by the minimum energy of a protein 
structure at thermodynamics equilibrium. Rather than making an account on the 
theory of the amino acid properties it aims in locating the protein’s free energy 
global minima as it resembles the conformation of the naive protein. Some of 
the essential force fields used are CHARMM, GROMOS, AMBER, ECEPP, and 
ROSETTA-ab initio.
Current Topics and Emerging Issues in Malaria Elimination
12
3.2.1.2 Based on experimentally determined 3D structure Knowledge approaches
Knowledge based approaches are another way of predicting the 3D structures. 
Currently, comparative modeling or better known as homology modeling is the 
most common and powerful technique utilized for predicting the tertiary structure 
of proteins. It compares the query sequence of protein with a similar sequence to 
that of a known crystal structure. Thus, a precise model can be established based 
on sequence similarities along with building the model and energy minimization. 
MODELER and Distance geometry are the most commonly used analysis tools.
Another approach is the threading which aims for selecting the most possible 
fold of the query sequence or recognizing the possible sequences which fold into the 
structure. Recognizing a fold needs the perfect alignment of query sequence to that 
of a folding motif ’s amino acids. Precise structure can be designed only if atomic 
level details of the folds are available [53].
3.2.1.3 Hierarchical methods
The last alternate approach for predicting protein structure is the Hierarchical 
approach which uses the overall hierarchy, i.e., primary to tertiary structure. Here 
the prediction of the secondary structure is done for understanding the associa-
tion between the primary sequence and the 3D structure. Few methods based on 
physicochemical feature approach, statistical approach, combinatorial approach, 
information on evolution and artificial intelligence approach have been adopted 
for predicting the secondary structure. Even though, using these algorithms the 
accuracy rate is still at 80% [54].
Intensive study of chloroquine (CQ ) drug resistance in P. falciparum identified 
transporter protein (PfCRT) association with the resistance. Antony et al. modeled 
both the wild and mutant type of PfCRT 3D structure in Robetta and I-TASSER 
using threading [53]. Similar work has been performed by Sanasam and Kumar. An 
essential protein of P. falciparum AMR1 has been identified as a potential vaccine 
candidate. They predicted the 3D structure of AMR1 in ROSETTA using an ab-initio 
approach. Further, they predicted the best B-cell and T-helper epitopes of the pro-
tein [55]. Borah et al. analyzed the sequence of HopS2 protein which revealed many 
essential regions of the protein secondary structure. The target is then subjected to 
homology modeling in Swiss model but for lack of low coverage of the sequence the 
target has been modeled using an ab-initio approach. MD simulation in 100 ns has 
validated the stability of the target protein [56].
3.2.2 Computer-aided drug design approaches
Experimentally screening thousands of compounds along with their targets is 
quite laborious as well as time consuming too. As a result, in-silico methods were 
adopted, to identify the perfect hits and also improvise the probability of finding a 
precise drug molecule. For initiating drug discovery and design, various techniques 
are available, which are mostly: ligand-based (LBDD) and structure-based (SBDD) 
drug designing. LBDD approach involves methods such as pharmacophore modeling 
and quantitative structure–activity relationships (QSAR) whereas the SBDD approach 
involves methods such as molecular docking and molecular dynamics simulation.
3.2.2.1 Quantitative structure–activity relationships (QSAR)
Development of a quantitative structure–activity relationship equation is 
entirely based on the assumption that the molecular structure can be quantitatively 
13
Plasmodium falciparum: Experimental and Theoretical Approaches in Last 20 Years
DOI: http://dx.doi.org/10.5772/intechopen.96529
correlated with the molecule’s physicochemical or biological activity. Thus, the 
working concept behind this methodology is the differences observed in the 
biological activity of a series of compounds which can be quantitatively correlated 
with the differences in their molecular structure [57]. The final outcome of a logical 
and mathematical procedure is known as the molecular descriptor and it should 
be able to transform the chemical information, encoded in a molecular symbolic 
representation [58].
Some of the commonly used descriptors are the hydrophobic descriptors 
which represent the whole molecule size or lipophilicity [59] using properties like 
the molecular weight, volume and logarithm of partition coefficient in 1-octanol 
and water (log P), etc. Steric descriptors are those which explain both the shape 
and size of the molecules and the substituents. Some commonly used steric 
descriptors are the Taft’s steric constant Es, molar refractivity (MR), surface areas, 
molecular volume, etc. Topological descriptors are obtained from hydrogen-
depleted molecular graphs. Wiener index, structural information content, Chi 
index, molecular similarity, electro-topological state atom (ETSA) indices and 
Kappa index, etc. are some of the commonly used Topological descriptors [60]. 
Electronic descriptors are those that can justify the electronic properties of a 
molecule and are represented by descriptors such as, the Hammett constant  
(σ, σ-, σ+), charge transfer constants, dipole moments, ionization constant pKa, 
∆pKa parameters derived from molecular spectroscopy and parameters derived 
from quantum chemical calculation. The quantum chemical descriptors based on 
density functional theory (DFT) and semi-empirical methods have been found 
to play a major role in QSAR studies. Some of the commonly used DFT-based 
descriptors are the chemical potential (μ), global hardness (η), global softness, 
electrophilicity index (ω), etc. The study for artemisinin (an important class of 
antimalarial drugs) and its derivatives using the DFT based descriptors confirmed 
that one of the molecules (molecule-13) was the most reactive considering the 
electronic configuration [61].
3.2.2.2 Pharmacophore modeling
Pharmacophore modeling is the assembling of all the frameworks of a par-
ticular molecule which are necessary features for a molecule to inhibit a target’s 
biological response. Over the course of time this methodology has become crucial 
tools in drug discovery and designing. Designing a model can be accomplished 
by using ligand based where the active molecules are superimposed and similar 
electronic and steric features of importance are considered and structure based 
where the interaction between the target and the ligand are explored [62]. Manhas 
et al. did a pharmacophore study where they attempted to identify novel inhibition 
against P. falciparum dihydroorotate dehydrogenase (PfDHODH) and also utilized 
docking and MD [63].
3.2.2.3 Molecular docking
SBDD is based on the target and the ligand’s 3D data whereas LBDD can be 
implied in absence of targets 3D structure. Here, the ligands were known which 
remained bound with the targets. Further, the targets were analyzed to decrypt 
the structural as well as chemical properties of the ligands. Molecular docking 
is divided into three types: flexible, semi-flexible and rigid docking. During the 
past decades, different types of approaches have been made like conformational 
sampling and induced fit models [64, 65]. Some examples are: GBVI/WSA, LUDI, 
Monte Carlo, GoldScore and AutoDock.
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Hazarika and Jha have considered three different types of docking programs viz. 
Molegro Virtual Docker, Glide and GOLD, a set of ligands screened out based on the 
druglikeness properties are considered for docking against the target protein influ-
enza endonuclease, RNA binding protein. The resulting target-ligand complexes 
lists are considered based on their scoring functions. Among the top 20 compounds, 
10 compounds were common in the mentioned software. Thus, indicating some 
consent of the compounds [66]. Thillainayagam et al. carried out an in-silico study 
by screening the set of pyrazole-pyrazoline against the target Histo aspartic protease 
(HAP). The target is docked with the set of the ligand (Asp 215, His 32 and Ser 35) as 
their binding site in Auto dock version 4.2. Further, MD simulation revealed HAP-
ligand as more stable than HAP [67].
3.2.2.4 Molecular dynamics
Molecular dynamics (MD) simulation technique allowed us to understand the 
time-dependent behavior of protein-ligand interactions. MD simulation mimics the 
moment of an atom; the fundamental unit of a molecule, and what it does in real 
life. In MD simulation, which is based on Newtonian mechanics, forces on each atom 
are computed provided we know the energy function and positions of the atoms in 
a system. Generally, 2 fs (femtosecond) is applied for simulating the atom which is 
integrated with the numerical movement. The common and popular engines avail-
able are: GROMACS, DESMOND, CHARMM, NAMD and AMBER. Their integra-
tion with message passing interface (MPI) has significantly reduced the overall 
computational time by making the engines utilize the cores simultaneously [68].
Hazarika and Jha have utilized molecular dynamics in measuring the interactiv-
ity of silver nanoparticles on human serum albumin (HSA), a transport protein. 
Sudden change in its structure can barricade the overall function. The HSA 
sequence analysis was done using BLASTP and MSA followed by the secondary 
structure analysis of HSA. Further, MD simulation was performed in GROMACS 
2016.4 version for checking the functionality of the nanoparticles with HSA [69]. 
In order to effectively challenge Epstein-Bar virus, Jakhmola et al. have applied 
molecular docking and MD simulation of glycoprotein H with different phyto-
chemicals and showed their potentials as virus specific therapeutics [70]. Saikia 
 et al. performed MD along with molecular docking to check the dynamics of pyra-
zinamide (PZA) and PZA-functionalized graphene interaction with pncA protein. 
A total of five sets of systems were subjected to MD simulation. Using Gromacs 
package 4.5.0 along with OPLS-AA force-field MD was performed [71].
3.2.3  Application examples of drug discovery against P. falciparum using 
Bioinformatics Approach
P. falciparum falcipains act on hemoglobin degradation, making it a potential 
target for drugs. Musyoka et al. performed an in-silico study on falcipain-2, falci-
pain-3 and their homologs. Using MODELER 9.10 homology models were prepared 
and docking was done in Autodock 4.2 using the 23 natural compounds against 11 
target proteins. Based on docking energies 3D similar search is performed in ZINC. 
Further, MD simulation confirms the interaction of the derivatives with the targets. 
Overall they provided a more effective derivative of the compounds, making it well 
tolerated among humans [72].
Phosphatidylinositol-4-OH kinase (PI(4)K) type IIIβ, a type of lipid kinase has 
been recognized as an essential imidazopyrazines target. Unavailability of crystal 
structure posed a challenge for drug development. So, Rajkhowa et al. performed 
an in-silico where they utilized homology modeling to model the PfPI(4)KIIIβ 3D 
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structure. And they validated the structure using MD simulations. Moreover, taking 
the toxicity and hERG liabilities as priorities screening was done for 178 compounds 
from PubChem database. The ligand and target were subjected to molecular dock-
ing in AutoDock 4.2. MD simulation was further utilized against the target-ligand 
complexes to check stability. The study reported a total of three inhibitors based on 
the analysis done [73].
4. Conclusion
Malaria, the world’s most regular and dreadful tropical disease, considerable 
actions have been undertaken to arrest or cure malaria from several decades. 
Diverse in silico attempts including high throughput screening that has screened 
out a number of novel drug molecules like phytochemicals which can be a potent 
antimalarial drug in near future, antimalarial target determination, modeling of 
target proteins using homology modeling, Pharmacophore modeling of derivatives 
in the existing resistant drugs, Ligand and structure based drug designing strategies 
for the development of potent drugs, along with several experimental techniques. 
However, it provides sensitivity along with specificity that varies resembling recent 
technical advances. RDTs are convenient and currently implemented in many 
remote settings but could lead to overdiagnosis and overtreatment, demanding 
upgraded quality control. Molecular-biological methodologies put forward the best 
sensitivities, they can be utilized to identify the development of drug-resistance, are 
useful for species identification, and also for quantifying parasite density with low 
parasitemia. However, out of reach to most and are restricted to clinical research. 
There are various possibilities and a wide range of applications of CRISPR/Cas9 
systems evolved in prokaryotes. Using this technique, gene drives to make mos-
quitoes resistant to malaria have already been planned and further study can be 
carried out with proper examinations. Also genetically engineered mosquitoes can 
be developed that produces almost entirely male offspring, consequently helping 
in malaria eradication. To lessen the parasite would call diagnostic tools which are 
non-invasive highly sensitive, vigorous and go with the environment established in 
particular regions.
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